+44 1865 248455
info@oxfordglobal.co.uk
Enquire
Twitter
Linkedin-in
RNA Therapeutics & Delivery US: Online
: Speakers
Speakers
29 - 30 June 2021 | EDT (UTC-4)
This event is part of our
Formulation & Delivery Series
. Please click here for more information on related events taking place throughout the year.
Home
Agenda
Speakers
Sponsorship
Attendees
Media
What to Expect
Menu
Home
Agenda
Speakers
Sponsorship
Attendees
Media
What to Expect
Book Now
RNA Therapeutics & Delivery US: Online
has now concluded. Please click here for more information on other events within our
Formulation & Delivery Series
, taking place throughout the year.
Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.
The following are confirmed speakers for RNA Therapeutics & Delivery US: Online
Andreas Kuhn
Senior Vice President, RNA Biochemistry & Manufacturing
BioNTech
Ash Dugar
Senior Vice president
Dyne Therapeutics
Carlo Zambonelli
Director, Analytical Develepment
Beam Therapeutics
Cees Can Rijn
Professor
University of Amsterdam
Charles Bowerman
Scientific Associate Director
Moderna
Christophe Quéva
Chief Scientific Officer
Oncorus
Cristina Ruedell Reschke
Royal College of Surgeons in Ireland
Lecturer
Denis Drygin
Chief Scientific Officer
Regulus Therapeutics
Fadee Mondalek
Head of Internal Development
Bayer
François Fuks
Professor & Director
Université libre de Bruxelles
Frank DeRosa
Chief Technology Officer
Translate Bio
Gene Liau
Chief Scientific Officer
Stoke Therapeutics
Hannah Pendergraff
Group Leader, Exosome Payloads
Evox Therapeutics
John Pasi
Professor & Director of Hemophilia Centre
Barts Health NHS Trust
Kari Sweeney Efferen
Director, Analytical & Formulation Development
Pfizer
Laura Sepp-Lorenzino
Chief Scientific Officer
Intellia Therapeutics
Marcel Blommers
Chief Scientific Officer
Saverna Therapeutics
Martin Akerman
Chief Executive Officer
Envisagenics
Muthiah Manoharan
Senior Vice President
Alnylam Pharmaceuticals
Patrick Baumhof
Vice president, Formulation & Delivery
CureVac
Patrick Lu
President & CEO, Founder
SiRNA Omics
Richard Geary
Executive Vice President, Development
Ionis Pharmaceuticals
Robert Ihry
Investigator II
Novartis
Sean Burns
Senior Director of Disease Biology
Intellia Therapeutics
Stefan Engelhardt
Director, Institute of Pharmacology & Toxicology
Technical University of Munich
Tod Woolf
Chief Executive Officer
ETAGEN